MSCM Cancer Center and Institute of Oncology Department of Breast Cancer and Reconstructive Surgery
- Address
- 5, W. K. Roentgena str, 02-781 Warsaw, Poland
MSCM Cancer Center and Institute of Oncology - Department of Breast Cancer and Reconstructive Surgery
The Department of Breast Cancer and Reconstructive Surgery at MSCM Cancer Center and Institute of Oncology is a specialized clinical research facility dedicated to advancing treatment strategies for breast cancer patients. The center focuses on innovative approaches to personalized medicine and comprehensive breast cancer care, combining cutting-edge therapeutic interventions with reconstructive surgical expertise.
- Adjuvant therapies for hormone receptor-positive (HR+/HER2-) early breast cancer
- Dynamic marker-adjusted personalized treatment protocols
- CDK4/6 inhibitor combination strategies with endocrine therapy
The department is actively engaged in Phase III clinical trials evaluating novel therapeutic combinations for intermediate to high-risk early breast cancer. Their research emphasizes the integration of genomic risk assessment with targeted therapies, particularly investigating the addition of abemaciclib to standard endocrine therapy regimens. This work aims to improve invasive disease-free survival outcomes through precision medicine approaches tailored to individual patient risk profiles.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in MSCM Cancer Center and Institute of Oncology Department of Breast Cancer and Reconstructive Surgery
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Phase III Randomized Controlled Trial of Abemaciclib Plus Endocrine Therapy Versus Endocrine Therapy in HR+/HER2- Early Breast Cancer with Intermediate to High Risk | WSG Westdeutsche Studiengruppe GmbH | Phase III | Not Recruiting | Jul 2020 | — |
IMP list
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Abemaciclib | 1 | Unknown | 2020-07-23 | 2020-07-23 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.